Poor solubility continues to limit the performance of many oral drug candidates. This session explores how strategic formulation design in oral solid dosage (OSD) development can enhance solubility and drive better bioavailability outcomes. From enabling technologies to rational design principles, attendees will gain practical insights into approaches that improve drug performance while supporting efficient and scalable development.
